Cypherpunk Technologies Q1 net loss widens

Cypherpunk Technologies

14/05/2026 12:13

Overview

US privacy technology firm's Q1 net loss widened

Research and development expenses dropped after completion of clinical trials

Company invested $5 mln in Zcash Open Development Labs and expanded ZEC holdings

Outlook

Company did not provide specific financial guidance or forecasts for the current or future periods in press release

Result Drivers

ZEC PRICE DECLINE - Net loss widened due to a $77.6 mln unrealized loss on ZEC holdings as the price of ZEC fell from $508.09 to $240.47 during Q1

LOWER R&D SPENDING - Research and development expenses fell after completion of clinical trials

HIGHER STOCK COMPENSATION - General and administrative expenses rose mainly due to increased stock-based compensation for employees and directors

Company press release: ID:nPreTc9lNa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 EPS
-$0.46
Q1 Net Income
-$77.20 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)